David Goodrich, Ph.D.
About David Goodrich, Ph.D.
David Goodrich, Ph.D., is a Principal Scientist at Bristol Myers Squibb in Seattle, Washington, with expertise in cell therapy, virology, infertility, and molecular diagnostics.
Title
David Goodrich, Ph.D., is a Principal Scientist at Bristol Myers Squibb, based in Seattle, Washington, United States. He has held this position since June 2020.
Professional Experience at Bristol Myers Squibb
Since June 2020, David Goodrich, Ph.D., has been working as a Principal Scientist at Bristol Myers Squibb. Based in Seattle, Washington, he contributes to the development and validation of new therapies and technologies. He brings his extensive expertise in cell therapy, virology, infertility, and molecular diagnostics to the role.
Previous Roles at WuXi Advanced Therapies
David Goodrich, Ph.D., worked as a Scientist at WuXi Advanced Therapies from 2018 to 2020. During his two-year tenure in Greater Philadelphia Area, he focused on advancing therapies and technologies in his field of expertise, including cell therapy and molecular diagnostics.
Program Manager Experience at RUCDR Infinite Biologics
From 2017 to 2018, David Goodrich, Ph.D., served as a Program Manager at RUCDR Infinite Biologics in Piscataway, New Jersey. Over the course of 11 months, he managed programs aimed at driving advancements in biology and biotechnology.
Academic Training and Early Research at Rutgers University
David Goodrich, Ph.D., completed his academic training at Rutgers University. He earned his Doctor of Philosophy (Ph.D.) in Molecular Biology from 2013 to 2016 and served as a Doctoral Fellow at Rutgers University Graduate School of Biomedical Sciences from 2013 to 2017. Additionally, he completed a postdoctoral fellowship at Rutgers Cancer Institute of New Jersey in 2017, contributing to research in cancer biology.